Logo image of NHTC

NATURAL HEALTH TRENDS CORP (NHTC) Stock Fundamental Analysis

NASDAQ:NHTC - Nasdaq - US63888P4063 - Common Stock - Currency: USD

4.58  0 (0%)

Fundamental Rating

3

NHTC gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 35 industry peers in the Personal Care Products industry. No worries on liquidiy or solvency for NHTC as it has an excellent financial health rating, but there are worries on the profitability. NHTC does not seem to be growing, but still is valued expensively. Finally NHTC also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

Quickly go to:

3

1. Profitability

1.1 Basic Checks

NHTC had positive earnings in the past year.
In the past year NHTC has reported a negative cash flow from operations.
In the past 5 years NHTC has always been profitable.
The reported operating cash flow has been mixed in the past 5 years: NHTC reported negative operating cash flow in multiple years.
NHTC Yearly Net Income VS EBIT VS OCF VS FCFNHTC Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

1.2 Ratios

NHTC has a Return On Assets of 0.95%. This is comparable to the rest of the industry: NHTC outperforms 57.14% of its industry peers.
NHTC's Return On Equity of 1.64% is fine compared to the rest of the industry. NHTC outperforms 65.71% of its industry peers.
Industry RankSector Rank
ROA 0.95%
ROE 1.64%
ROIC N/A
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
NHTC Yearly ROA, ROE, ROICNHTC Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

1.3 Margins

NHTC has a Profit Margin of 1.18%. This is comparable to the rest of the industry: NHTC outperforms 54.29% of its industry peers.
In the last couple of years the Profit Margin of NHTC has declined.
The Gross Margin of NHTC (74.04%) is better than 85.71% of its industry peers.
In the last couple of years the Gross Margin of NHTC has remained more or less at the same level.
Industry RankSector Rank
OM N/A
PM (TTM) 1.18%
GM 74.04%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
NHTC Yearly Profit, Operating, Gross MarginsNHTC Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

More info and screens

7

2. Health

2.1 Basic Checks

NHTC does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NHTC remains at a similar level compared to 1 year ago.
Compared to 5 years ago, NHTC has more shares outstanding
There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
NHTC Yearly Shares OutstandingNHTC Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
NHTC Yearly Total Debt VS Total AssetsNHTC Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

2.2 Solvency

An Altman-Z score of 2.03 indicates that NHTC is not a great score, but indicates only limited risk for bankruptcy at the moment.
With a Altman-Z score value of 2.03, NHTC perfoms like the industry average, outperforming 42.86% of the companies in the same industry.
There is no outstanding debt for NHTC. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z 2.03
ROIC/WACCN/A
WACC8.93%
NHTC Yearly LT Debt VS Equity VS FCFNHTC Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M

2.3 Liquidity

A Current Ratio of 2.35 indicates that NHTC has no problem at all paying its short term obligations.
Looking at the Current ratio, with a value of 2.35, NHTC is in the better half of the industry, outperforming 62.86% of the companies in the same industry.
NHTC has a Quick Ratio of 2.22. This indicates that NHTC is financially healthy and has no problem in meeting its short term obligations.
The Quick ratio of NHTC (2.22) is better than 80.00% of its industry peers.
Industry RankSector Rank
Current Ratio 2.35
Quick Ratio 2.22
NHTC Yearly Current Assets VS Current LiabilitesNHTC Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M

More info and screens

0

3. Growth

3.1 Past

NHTC shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by 0.00%.
The earnings per share for NHTC have been decreasing by -17.90% on average. This is quite bad
The Revenue has decreased by -0.63% in the past year.
The Revenue for NHTC have been decreasing by -11.15% on average. This is quite bad
EPS 1Y (TTM)0%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%-50%
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-1.92%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NHTC Yearly Revenue VS EstimatesNHTC Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
NHTC Yearly EPS VS EstimatesNHTC Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 0.01 0.02 0.03 0.04 0.05

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 91.60, the valuation of NHTC can be described as expensive.
NHTC's Price/Earnings ratio is in line with the industry average.
Compared to an average S&P500 Price/Earnings ratio of 27.28, NHTC is valued quite expensively.
Industry RankSector Rank
PE 91.6
Fwd PE N/A
NHTC Price Earnings VS Forward Price EarningsNHTC Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
NHTC Per share dataNHTC EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 2 3

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

7

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 18.43%, NHTC is a good candidate for dividend investing.
NHTC's Dividend Yield is rather good when compared to the industry average which is at 5.83. NHTC pays more dividend than 100.00% of the companies in the same industry.
Compared to an average S&P500 Dividend Yield of 2.42, NHTC pays a better dividend.
Industry RankSector Rank
Dividend Yield 18.43%

5.2 History

The dividend of NHTC has a limited annual growth rate of 4.44%.
NHTC has paid a dividend for at least 10 years, which is a reliable track record.
NHTC has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)4.44%
Div Incr Years0
Div Non Decr Years10
NHTC Yearly Dividends per shareNHTC Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.2 0.4 0.6

5.3 Sustainability

NHTC pays out 1820.75% of its income as dividend. This is not a sustainable payout ratio.
DP1820.75%
EPS Next 2YN/A
EPS Next 3YN/A
NHTC Yearly Income VS Free CF VS DividendNHTC Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M
NHTC Dividend Payout.NHTC Dividend Payout, showing the Payout Ratio.NHTC Dividend Payout.PayoutRetained Earnings

More info and screens

NATURAL HEALTH TRENDS CORP

NASDAQ:NHTC (7/3/2025, 10:56:12 AM)

4.58

0 (0%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupHousehold & Personal Products
GICS IndustryPersonal Care Products
Earnings (Last)04-30 2025-04-30/bmo
Earnings (Next)07-29 2025-07-29
Inst Owners9.72%
Inst Owner Change-4.52%
Ins Owners15.6%
Ins Owner Change0%
Market Cap52.72M
Analysts0
Price TargetN/A
Short Float %0.4%
Short Ratio1.09
Dividend
Industry RankSector Rank
Dividend Yield 18.43%
Yearly Dividend0.8
Dividend Growth(5Y)4.44%
DP1820.75%
Div Incr Years0
Div Non Decr Years10
Ex-Date05-13 2025-05-13 (0.2)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 91.6
Fwd PE N/A
P/S 1.23
P/FCF N/A
P/OCF N/A
P/B 1.71
P/tB 1.71
EV/EBITDA N/A
EPS(TTM)0.05
EY1.09%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.3
FCFYN/A
OCF(TTM)-0.3
OCFYN/A
SpS3.71
BVpS2.68
TBVpS2.68
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.95%
ROE 1.64%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 1.18%
GM 74.04%
FCFM N/A
ROA(3y)0.74%
ROA(5y)0.82%
ROE(3y)1.23%
ROE(5y)1.35%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3Y-10.12%
PM growth 5YN/A
GM growth 3Y-0.45%
GM growth 5Y-0.03%
F-Score4
Asset Turnover0.8
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 49.21%
Cap/Sales 0.15%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.35
Quick Ratio 2.22
Altman-Z 2.03
F-Score4
WACC8.93%
ROIC/WACCN/A
Cap/Depr(3y)47.19%
Cap/Depr(5y)53.89%
Cap/Sales(3y)0.17%
Cap/Sales(5y)0.25%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)0%
EPS 3Y-17.9%
EPS 5YN/A
EPS Q2Q%-50%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-0.63%
Revenue growth 3Y-10.54%
Revenue growth 5Y-11.15%
Sales Q2Q%-1.92%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.87%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-5.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-7.25%
OCF growth 3YN/A
OCF growth 5YN/A